CVC, NSSK weigh $3.2bn Kobayashi Pharmaceutical take-private
Friday, September 25, 2026 · first reported by Private Equity Wire
CVC Capital Partners and Nippon Sangyo Suishin Kiko (NSSK) considering joint bid of ~JPY500bn ($3.2bn) to take Japanese healthcare company Kobayashi Pharmaceutical private.
- Deal value
- $3.2B
- Asset class
- Private equity
- Geography
- Asia-Pacific
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on CVC Capital Partners
Everything on this firm →More in Deals
From the same day- Oaktree agrees to €810m sale of Italian power firm COL Group to EatonPE Hub
- Eagle Point backs $450m US government-leased real estate recapitalisationIPE Real Assets
- Madison Dearborn to take Marygold privatePE Hub
- Bain Capital acquires SOLitude Lake Management from Rentokil Initial for $230M enterprise value (cash-free, debt-free)Private Equity Professional
- PE firm Uplift adds Arkansas injury practice to law platformPrivate Equity Wire
- Butterfly Equity acquires Sabert, a manufacturer of single-use plastic, paper and molded fiber food containersPrivate Equity Professional